Wikipedia -WSS

Wikipedia

author：explore 2025-09-06 02:13:27 - browse：3

Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.

Additionally, Apellis confirmed one additional case of the severe and potentially blinding side effect, known as retinal occlusive vasculitis, or ROV, that occurred in May. But with thousands of more Syfovre eye injections also performed, the overall frequency of ROV remains unchanged and rare, even with the added scrutiny and increased physician monitoring.

Apellis shares rose 30% to $40 in Wednesday’s pre-market trading on the growing belief amongst investors that Syfovre’s safety crisis is abating.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Pharmacists can make shortage drugs, but at what cost?

WSS

Impact of Dobbs ruling felt at reproductive medicine meeting

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Tome Biosciences co

FDA warns J&J's Abiomed: We will regulate your software

Congress must protect the remaining independent doctors

AMAs digital advisors table RPM coding reform proposal, again

hotspot

Wikipedia

Wikipedia

The high cost of giving birth even with insurance

Why health workers in Gaza are injured or die at high rates

Drug repurposing or repositioning? The language matters

Why health workers in Gaza are injured or die at high rates

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Guidelines to prevent youth baseball injuries need more muscle

Pharmacists can make shortage drugs, but at what cost?

As demand for Covid shots wanes, Moderna seeks its next success

STAT Summit: Biotech founders on deal

entertainment

2023 STAT Wunderkinds: get to know the winners

Latigo launches with $135 million for Vertex

STAT Summit: How a Chicago ER doctor tackles gun violence

STAT Readout Newsletter: Today's biggest biotech updates

NIH confirmation hearing shows politicization of research

Ebola vaccine can save some who are already sick, per new study

knowledge

knowledge

explore

explore